About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,076 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,076 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 981-1000 of 13,076 trials

CompletedLow-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway GliomaThis randomized phase II trial studies how well low-dose lenalidomide works compared with high-dose lenalidomide in treating younger patients with juvenile pilocytic astrocytomas…NCT01553149·Birmingham, Alabama and 125 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedHealing Hearts and Mending Minds in Older Adults Living With HIVThe purpose of this study is to see if exercise is helpful for improving memory, concentration thinking abilities, physical function, and quality of life for adults aged 50 to 89…NCT02711878·Atlanta, Georgia and 2 others

CompletedA Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)The primary objective of the 1701-202 STRONG SCD study is to evaluate the safety and tolerability of different dose levels of IW-1701 compared with placebo when administered daily…NCT03285178·Orange, California and 36 others

Active not recruitingTesting Immunotherapy Versus Observation in Patients With HPV Throat CancerThis phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant…NCT03811015·Fairhope, Alabama and 726 others

CompletedTesting Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American CaregiversTwo arm study, experimental and control, to explore the impact of an online training program to help community health workers conduct effective outreach to support the dental…NCT05511935·Atlanta, Georgia

TerminatedEfficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)The main purpose of this study was to assess the safety and efficacy of MK-1942 as adjunctive therapy in participants with mild to moderate Alzheimer's Disease (AD) dementia.NCT05602727·Phoenix, Arizona and 73 others

TerminatedStudy to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple MyelomaThe primary objective of the study is to evaluate the safety and tolerability of KITE-585, an autologous engineered chimeric antigen receptor (CAR) T-cell product targeting a…NCT03318861·Los Angeles, California and 8 others

RecruitingDouble-blind, Placebo-controlled Study in Adults With Major Depressive DisorderThis study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorderNCT07226661·Birmingham, Alabama and 39 others

CompletedCompare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CMLTwo-arm, randomized, open-label trial designed to evaluate the efficacy and safety of bosutinib alone compared to imatinib alone in subjects newly diagnosed with chronic phase…NCT00574873·Anaheim, California and 164 others

CompletedElectronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care SystemThe premise for the study is that a tailored approach for rural young men who have sex with men (YMSM), addressing known barriers of transportation, access to providers, and…NCT03729570·Birmingham, Alabama and 3 others

Active not recruitingUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop TrialThis phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma that cannot be…NCT04462406·Fairhope, Alabama and 481 others

CompletedA Study of TAK-861 in Participants With Narcolepsy Type 2The main aim is to evaluate the effect of TAK-861 on symptoms of narcolepsy, including excessive daytime sleepiness (EDS) as measured by sleep latency from the Maintenance of…NCT05687916·Birmingham, Alabama and 55 others

RecruitingRegistry of Patients With Brain Tumors Treated With STaRT (GammaTiles)The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.NCT04427384·Phoenix, Arizona and 53 others

CompletedStudy to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the BrainThis is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118436) and Trametinib (GSK1120212) combination therapy in subject with BRAF mutation-positive melanoma…NCT02039947·Birmingham, Alabama and 46 others

CompletedExenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusThis study will compare the impact of including exenatide once weekly in addition to usual care vs. usual care without exenatide on major cardiovascular outcomes as measured by…NCT01144338·Birmingham, Alabama and 628 others

RecruitingOutcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac ProceduresThe incidence of moderate to severe congenital heart disease (CHD) in the United States is estimated to be 6 per 1000 live-born full term infants.NCT04604418·Los Angeles, California and 9 others

CompletedPanobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple MyelomaNote: The study data was transferred to zr pharma\& following the divestment of panobinostat to pharma\&.NCT02654990·Fayetteville, Arkansas and 79 others

CompletedDose-Response Effects of Whole Body Vibration on Spasticity and Walking in SCIThis study will enroll people with SCI who have spasticity and some ability to walk.NCT02340910·Atlanta, Georgia

CompletedA Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy AdultsThe purpose of this study is to determine if a single dose of vitamin D administered orally in the fall will provide adequate vitamin D in healthy individuals for the duration of…NCT01924910·Atlanta, Georgia

CompletedEfficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.The purpose of the protocol is to evaluate the efficacy and safety of Dysport® using 2 mL dilution compared with placebo for the treatment of Cervical Dystonia.NCT01753310·Birmingham, Alabama and 41 others

PreviousPage 50 of 654Next

in Atlanta

Heart Diseasein Atlanta